SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-15-000194
Filing Date
2015-08-14
Accepted
2015-08-14 16:42:11
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 jun1510qproctectvedgar5.htm 10-Q 225444
2 exhibit31.htm EX-31 9304
3 exhibit32.htm EX-32 4598
  Complete submission text file 0001551163-15-000194.txt   602253

Data Files

Seq Description Document Type Size
4 prtt-20150630.xml EX-101.INS 27804
5 prtt-20150630.xsd EX-101.SCH 8524
6 prtt-20150630_cal.xml EX-101.CAL 9926
7 prtt-20150630_def.xml EX-101.DEF 6045
8 prtt-20150630_lab.xml EX-101.LAB 48931
9 prtt-20150630_pre.xml EX-101.PRE 38895
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 151056572
SIC: 2834 Pharmaceutical Preparations